Mitapivat for anemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Jul 2025: Trial registered, NCT07055243
  2. 20 Oct 2025: Trial started, NCT07055243

The trials

NCT07055243: To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.

State
Under way
Phase
Phase 2
People
9 taking part
Started
20 Oct 2025
Primary completion
Oct 2029
Arms
Mitapivat
Results
None posted
  1. 8 Jul 2025: Trial registered
  2. 20 Oct 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.